Evidence review
Diarrhea on Semaglutide or Tirzepatide: What to Track and When to Get Help
The short answer
Diarrhea is a recognized side effect of semaglutide and tirzepatide, but infections and other medicines can also cause it. Contact your clinician for persistent symptoms or dehydration. Blood in the stool, severe pain, frequent vomiting or marked weakness need prompt assessment. Discuss treatment and dose changes with the prescriber.
Section index07
Loose stools after a new prescription raise two immediate questions: is the medicine involved, and is it safe to wait? The timing matters, but it cannot establish the cause. A brief change in bowel habits and diarrhea that leaves you unable to drink or work need different responses.
This guide covers semaglutide products such as Ozempic and Wegovy and tirzepatide products such as Mounjaro and Zepbound. Their indications and instructions differ. Keep the name of your actual product available when you contact the care team; “my GLP-1” may not give them enough information.
CoreAge Rx
$99/mo sema · $149/mo tirz
- Semaglutide
- $99/mo
- Tirzepatide
- $149/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
- Modeled / yr
- $1,188
CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.
Read the full CoreAge Rx review →Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never moves the Index. See our disclosure.
MEDGm
67/100- Semaglutide
- $299/moMonth-to-month (the advertised $179 is the first month only, after an automatically applied coupon)
- Tirzepatide
- $399/moMonth-to-month (the advertised $279 is the first month only)
Can semaglutide or tirzepatide cause diarrhea?
Yes. Diarrhea appears in the adverse-reaction information for Wegovy and Zepbound. Both labels also warn about kidney injury associated with fluid loss from gastrointestinal symptoms12. That makes hydration and symptom severity more useful questions than whether a symptom is merely listed as common.
GI symptoms can occur around treatment changes. However, a symptom beginning after an injection does not prove the injection caused it. Foodborne illness, viral infections, antibiotics, metformin and other medicines may also be relevant. NIDDK describes several potential causes, including infections and difficulty digesting some carbohydrates3.
For the overall pattern of side effects, see our separate semaglutide and tirzepatide guides. Comparing percentages from unrelated trials does not predict which product you personally tolerate better. Different participants, doses and reporting methods can change the numbers.
How long does it last?
There is no reliable countdown for an individual episode. A trial's average experience cannot tell you when your symptoms will stop. Tell the clinician how long the diarrhea has lasted and whether it is improving, recurring after each dose or becoming more frequent.
NIDDK advises adults to contact a doctor right away for diarrhea lasting more than two days, high fever or six or more loose stools in a day. It also identifies dehydration, severe pain, frequent vomiting, and stools containing blood, pus or a black tar-like appearance as reasons for prompt medical help3. You do not have to wait two days when a warning sign is already present.
People with kidney disease, immune suppression or other conditions may need earlier assessment. An unanswered routine portal message is not an appropriate route for an emergency. If symptoms are severe or you feel faint or confused, seek urgent care instead of waiting for the next scheduled check-in.
A useful symptom record
Write down when symptoms began, the number of loose stools, any vomiting, fever or abdominal pain, and whether you can drink and urinate normally. Include the date and strength of your latest dose, any recent increase and any missed doses. This gives the prescriber a timeline rather than an impression such as “my stomach is off.”
List new medicines and supplements, including laxatives and magnesium products. Mention recent travel, sick contacts and any antibiotics. Tell the clinician if you used an over-the-counter treatment and what happened afterward. Do not omit a product because it was sold as natural or digestive support.
A short record is enough. You do not need an expensive tracking subscription. The purpose is to make a clinical conversation more accurate, rather than to prove that every meal or symptom has a single identifiable trigger.
Fluids, electrolytes and food
Replacing fluid losses matters. NIDDK discusses fluids and electrolytes, including oral rehydration solutions, in diarrhea treatment. People with conditions such as diabetes or kidney disease should ask which fluid plan is appropriate4. A sports drink, electrolyte powder and oral rehydration solution are not automatically interchangeable for every patient.
Ask your care team or pharmacist what to use and how to recognize inadequate hydration. Very little urine, increasing dizziness or inability to keep drinks down warrant assessment. Do not force a generic daily water target if you have a fluid restriction. The kidney safety guide explains why fluid losses deserve attention even when a medication has evidence of kidney benefit in a different clinical setting.
When appetite returns, ask about returning to your usual tolerated foods. Prolonged fasting is not a routine solution for diarrhea. A temporary food adjustment should still consider adequate nutrition, especially when low appetite already makes meals difficult. Our GLP-1 nutrition guide covers questions about maintaining intake without assuming that you need branded shakes or supplements.
Should you take an anti-diarrhea medicine?
Ask a clinician or pharmacist whether one is suitable. Diarrhea with blood or fever should not simply be suppressed with an over-the-counter drug while the cause goes unassessed. NIDDK cautions against these medicines in some circumstances and notes limits in evidence for probiotics4. A product advertised as a GLP-1 gut repair supplement is not an established requirement of treatment.
Explain all symptoms together. Alternating diarrhea and constipation, persistent vomiting, or severe pain may change the evaluation. Buying several remedies at once also makes it harder to identify what helped and what caused another problem.
What about the next dose or dose increase?
Discuss ongoing symptoms before the next planned increase. An expert consensus on GLP-1 gastrointestinal effects emphasizes assessing tolerability and individualizing treatment5. That is a reason to contact the prescriber, rather than a do-it-yourself dosing schedule.
Do not double a dose, split a pen or improvise a smaller compounded dose to solve diarrhea. If symptoms interrupted treatment, tell the clinician how long the gap lasted. A missed dose or longer restart can involve different instructions depending on the product.
Choose support you can actually use
Before enrolling with a telehealth program, ask who assesses persistent symptoms, whether a visit costs extra and how urgent concerns are handled. Confirm what happens to an automatic refill while a treatment change is being considered. A low drug price is less helpful if you cannot reach the person managing your prescription.
Our provider reviews describe published program terms, while the research library explains the clinical evidence behind common questions. Use the two together: compare support and total costs, then discuss the medical plan with a clinician who knows your history.
Frequently asked questions
Does diarrhea mean a GLP-1 is working?
No. Diarrhea is an adverse symptom, not a reliable marker of weight-loss benefit. Report severity and persistence to the prescriber.
Can diarrhea cause kidney problems?
Fluid loss can contribute to dehydration and kidney injury. Wegovy and Zepbound labeling warns about this risk. Seek assessment if symptoms persist or hydration is difficult.
Should I stop or lower my dose?
Contact the prescriber for a product-specific plan. Severe symptoms need prompt assessment; do not improvise a dosing change while waiting for routine follow-up.
References
- Novo Nordisk (2026). Wegovy prescribing information, revised June 2026. Prescribing information. https://www.novo-pi.com/wegovy.pdf
- Eli Lilly and Company (2026). Zepbound prescribing information, revised August 2026. Prescribing information. https://pi.lilly.com/us/zepbound-uspi.pdf
- National Institute of Diabetes and Digestive and Kidney Diseases (2024). Symptoms & Causes of Diarrhea. NIDDK. https://www.niddk.nih.gov/health-information/digestive-diseases/diarrhea/symptoms-causes
- National Institute of Diabetes and Digestive and Kidney Diseases (2024). Treatment of Diarrhea. NIDDK. https://www.niddk.nih.gov/health-information/digestive-diseases/diarrhea/treatment
- Gorgojo-Martínez JJ et al. (2022). Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with GLP-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of Clinical Medicine. https://pubmed.ncbi.nlm.nih.gov/36614945/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Keep exploring
Nausea on Ozempic, Wegovy or Zepbound: Food Tolerance, Hydration and Follow-Up
What to record when GLP-1 nausea starts, how to discuss food tolerance and hydration, and when symptoms need medical assessment.
ReadConstipation on Ozempic, Wegovy or Zepbound: What to Track and When to Get Help
How to discuss GLP-1 constipation, review food and fluid intake, recognize warning signs and compare the follow-up support in your plan.
ReadAcid Reflux and Sulfur Burps on GLP-1 Treatment: What the Evidence Supports
Wegovy and Zepbound can cause belching and reflux. Understand sulfur-burp claims, food and timing questions, and symptoms that need medical assessment.
ReadLow Blood Sugar on Semaglutide or Tirzepatide: Risk, Symptoms and Planning
Understand low blood sugar with semaglutide or tirzepatide, the importance of insulin and sulfonylureas, and what to ask about monitoring and rescue plans.
ReadGLP-1s and Gastroparesis: Delayed Stomach Emptying, Symptoms and Evaluation
Understand delayed stomach emptying with GLP-1 medicines, why nausea alone is not a gastroparesis diagnosis, and when persistent symptoms need assessment.
ReadGLP-1 Kidney Safety: Dehydration Warnings and What FLOW Actually Found
Separate GLP-1 dehydration-related kidney warnings from Ozempic kidney benefits in type 2 diabetes and CKD. Learn what to ask about symptoms and monitoring.
Read